Decode Civils CAShorts
EconomyPrelimsGS3

Centre extends PLI scheme for medical devices to 2035-36, invites applications

By CAShorts DeskPublished Source: PIB (Department of Pharmaceuticals, Nov 2026; Union Cabinet, 2020 and 2023); Department of Pharmaceuticals PLI guidelines, 2023.

Centre extends PLI scheme for medical devices to 2035-36, invites applications
Illustration (AI-generated)

The Centre has extended the Production Linked Incentive (PLI) Scheme for medical devices up to 2035-36. The Department of Pharmaceuticals invited fresh applications on 10 November 2026. About Rs 2,700 crore of the scheme's outlay will fund the new round. Firms get three years to set up their plants. Applicants may file any number of applications.

Syllabus: Prelims · Current Affairs & IR; GS3 · Liberalisation & Industry; GS2 · Government Policies

Why this matters for UPSC

GS3 economy: industrial policy and Production Linked Incentive (PLI) schemes. Prelims can ask the scheme's ministry and incentive design; Mains, import dependence in medical devices.

Why it matters

A hospital buying a CT scanner or a dialysis machine today often pays for an imported unit or one put together from imported parts. The new round pays makers more for building critical components and high-end machines at home, so more of each device's value is added in India. If that works, hospitals could buy devices at lower prices and depend less on foreign suppliers when trade is disrupted. Small firms that make parts stand to win orders as larger makers buy locally. Dropping the sales floor lets newer firms claim support while their plants are still ramping up. The risk is that support runs for years without firms becoming competitive enough to sell abroad.

Prelims pointers

  • The PLI Scheme for Medical Devices is run by the Department of Pharmaceuticals through a Project Management Agency the Department nominates.
  • Under the 2023 guidelines, incentive equals net incremental sales of eligible products over the base year 2019-20 multiplied by the rate of incentive, which was 5%.
  • PLI-MD backs greenfield projects; spending on land and buildings is excluded from committed investment.
  • Look-alike: the Medical Device Parks scheme (Rs 400 crore, 2020) gives States up to Rs 100 crore per park via a State Implementing Agency; PLI pays manufacturers on sales.
  • The four Medical Device Parks supported by the Centre are in Himachal Pradesh, Madhya Pradesh, Tamil Nadu and Uttar Pradesh.
  • The Empowered Committee under the 2023 PLI-MD guidelines is chaired by the CEO of NITI Aayog.
  • The National Medical Devices Policy, 2023 seeks a 10-12% share of the global market over 25 years through six strategy areas.

Practise a UPSC-style question

With reference to the Production Linked Incentive (PLI) Scheme for Medical Devices, consider the following statements:

1. The incentive is calculated on incremental sales of eligible products over a base year.

2. The scheme is implemented through a Project Management Agency nominated by the Department of Pharmaceuticals.

3. Expenditure on land and factory buildings counts towards an applicant's committed investment.

Which of the statements given above is/are correct?

  1. (a) 1 and 2 only
  2. (b) 2 and 3 only
  3. (c) 1 and 3 only
  4. (d) 1, 2 and 3
Show the answer

Answer: (a) 1 and 2 only

Answer: (a) 1 and 2 only. The scheme rewards extra sales and runs through a PMA; land and buildings do not count.

Statement 1: correct. The 2023 guidelines compute the incentive as net incremental sales of eligible products over the base year 2019-20, multiplied by the rate of incentive.

Statement 2: correct. The 2020 Cabinet approval said a Project Management Agency nominated by the Department of Pharmaceuticals would implement the PLI scheme.

Statement 3: incorrect. The 2023 guidelines exclude spending on land and building from the scheme; it is not considered for eligibility.

Eliminate: statement 3 is false, as land and buildings are excluded. Out: (b), (c), (d).

Trap: Sounds right. Land and buildings feel like part of any factory investment, so a student may assume they count; the guidelines leave them out.

Remember: PLI pays on incremental sales over a base year; investment counted is plant, machinery, R&D and technology transfer.

More from the 12 November 2026 edition

All stories of 12 November 2026

More Economy current affairs